Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury

Neuroscience

Volumn 167, Issue 3, 2010, Pages 716-723

  Leroux, P ^a   Hennebert, C ^a   Catteau, J ^a   Legros, H ^a   Hennebert, O ^a   Laudenbach, V ^a   Marret, S ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cerebral palsy; N methyl d aspartic acid; Perinatal asphyxia; Prematurity

Indexed keywords

ACETYLSALICYLIC ACID; BETAMETHASONE; GLUTAMIC ACID; IBOTENIC ACID; INDOMETACIN; LYSINE ACETYLSALICYLATE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; EXCITOTOXICITY; LOW DRUG DOSE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT RESPONSE; WHITE MATTER;

ACETAMINOPHEN; ADRENAL CORTEX HORMONES; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BETAMETHASONE; BRAIN; BRAIN DAMAGE, CHRONIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ENCEPHALITIS; FEMALE; IBOTENIC ACID; INDOMETHACIN; MICE; NERVE FIBERS, MYELINATED; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME;

EID: 77951299109     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.02.042     Document Type: Article

References (44)

1. Acarin L., Gonzalez B., Castellano B. Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage. Stroke 2002, 33:2499-2505.
2. Adde-Michel C., Staquet P., Arsac M., Marret S. Evolution of extreme prematurity in a "haut-normand" level-3 center: comparison between 1997 and 2000. Arch Pediatr 2004, 11:1512-1513.
3. Anderson B.J. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth 2008, 18:915-921.
4. Anderson B.J., Allegaert K. Intravenous neonatal paracetamol dosing: the magic of 10 days. Paediatr Anaesth 2009, 19:289-295.
5. Arquié C., Leroux P., Bodenant C., Laquerrière A., Marpeau L., Marret S. Glucocorticoid treatment in an ischaemic-like excitotoxic model of leucomalacia in mice. Br J Obstet Gynaecol 2002, 109:989-996.
6. Baier R.J. Genetics of perinatal brain injury in the preterm infant. Front Biosci 2006, 11:1371-1387.
7. Barrington K.J. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001, 1:1.
8. Bass W.T., Buescher E.S., Hair P.S., White L.E., Welch J.C., Burke B.L. Proinflammatory cytokine-receptor interaction model improves the predictability of cerebral white matter injury in preterm infants. Am J Perinatol 2008, 25:211-218.
9. Baud O., Foix-L'Helias L., Kaminski M., Audibert F., Jarreau P.H., Papiernik E., Huon C., Lepercq J., Dehan M., Lacaze-Masmonteil T. Antenatal glucocorticoid treatment and cystic periventricular leucomalacia in very premature infants. N Engl J Med 1999, 341:1190-1196.
10. Blobaum A.L., Marnett L.J. Structural and functional basis of cyclooxygenase inhibition. J Med Chem 2007, 50:1425-1441.
11. Botting R.M. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses. J Physiol Pharmacol 2006, 57(Suppl 5):113-124.
12. Candelario-Jalil E., Fiebich B.L. Cyclooxygenase inhibition in ischemic brain injury. Curr Pharm Des 2008, 14:1401-1418.
13. Dammann O., O'Shea T.M. Cytokines and perinatal brain damage. Clin Perinatol 2008, 35:643-663. v.
14. Dommergues M.A., Patkai J., Renaud J.C., Evrard P., Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000, 47:54-63.
15. Duley L., Henderson-Smart D.J., Meher S., King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, 2. CD 004659.
16. Dumuis A., Sebben M., Haynes L., Pin J.P., Bockaert J. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 1988, 336:68-70.
17. Eberhardt W., Kilz T., Akool el-S., Muller R., Pfeilschifter J. Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cells. Biochem Pharmacol 2005, 70:433-445.
18. Favrais G., Schwendimann L., Gressens P., Lelievre V. Cyclooxygenase-2 mediates the sensitizing effects of systemic IL-1-beta on excitotoxic brain lesions in newborn mice. Neurobiol Dis 2007, 25:496-505.
19. Foix-L'Helias L., Marret S., Ancel P.Y., Marchand L., Arnaud C., Fresson J., Picaud J.C., Roze J.C., Theret B., Burguet A., Larroque B., Kaminski M. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study. BJOG 2008, 115:275-282.
20. Folkerth R.D. Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol 2006, 9:3-13.
21. Graham G.G., Scott K.F. Mechanism of action of paracetamol. Am J Ther 2005, 12:46-55.
22. Gressens P., Marret S., Evrard P. Developmental spectrum of excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates. Neuropathol Appl Neurobiol 1996, 22:498-502.
23. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996, 274:1383-1385.
24. Hagberg H., Thornberg E., Blennow M., Kjellmer I., Lagercrantz H., Thiringer K., Hamberger A., Sandberg M. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Acta Paediatr 1993, 82:925-929.
25. Halliday H.L., Ehrenkranz R.A., Doyle L.W. Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009, 1. CD001146.
26. Harding D.R., Humphries S.E., Whitelaw A., Marlow N., Montgomery H.E. Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2007, 92:F108-F112.
27. Hennebert O., Marret S., Carmeliet P., Gressens P., Laquerrière A., Leroux P. Role of tissue derived plasminogen activator (t-PA) in an excitotoxic mouse model of neonatal white matter lesions. J Neuropathol Exp Neurol 2004, 63:53-63.
28. Herrera C., Holberton J., Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2007, 2. CD003480.
29. Himmelmann K., Hagberg G., Beckung E., Hagberg B., Uvebrant P. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998. Acta Paediatr 2005, 94:287-294.
30. Husson I., Mesplès B., Bac P., Vamecq J., Evrard P., Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2001, 51:82-92.
31. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001, 14:89-94.
32. Kaufmann W.E., Worley P.F., Taylor C.V., Bremer M., Isakson P.C. Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome. Brain Dev 1997, 19:25-34.
33. Kawai S., Nishida S., Kato M., Furumaya Y., Okamoto R., Koshino T., Mizushima Y. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J Pharmacol 1998, 347:87-94.
34. Laudenbach V., Calo G., Guerrini R., Lamboley G., Benoist J.F., Evrard P., Gressens P. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J Clin Invest 2001, 107:457-466.
35. Leroux P., Hennebert O., Legros H., Laudenbach V., Carmeliet P., Marret S. Role of tissue-plasminogen activator (t-PA) in a mouse model of neonatal white matter lesions: interaction with plasmin inhibitors and anti-inflammatory drugs. Neuroscience 2007, 146:670-678.
36. Marret S., Marchand L., Kaminski M., Larroque B., Arnaud C., Truffert P., Thiriez G., Fresson J., Roze J.C., Ancel P.Y. Effects of prenatal low-dose aspirin on neurodevelomental and behavioral outcomes of children born very-preterm: results from the EPIPAGE study. Pediatrics 2010, 125:e29-e34.
37. Marret S., Mukendi R., Gadisseux J.F., Gressens P., Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995, 54:358-370.
38. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998, 4:291-297.
39. Mesples B., Plaisant F., Fontaine R.H., Gressens P. Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity. Acta Paediatr 2005, 94:185-190.
40. Parfenova H., Levine V., Gunther W.M., Pourcyrous M., Leffler C.W. COX-1 and COX-2 contributions to basal and IL-1beta-stimulated prostanoid synthesis in human neonatal cerebral microvascular endothelial cells. Pediatr Res 2002, 52:342-348.
41. Schwab J.M., Beschorner R., Meyermann R., Gozalan F., Schluesener H.J. Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury. J Neurosurg 2002, 96:892-899.
42. Tahraoui S.L., Marret S., Bodénant C., Leroux P., Dommergues M.A., Evrard P., Gressens P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001, 11:56-71.
43. Toti P., De Felice C., Schurfeld K., Stumpo M., Bartolommei S., Lombardi A., Petraglia E., Buonocore G. Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain. An autopsy study. J Submicrosc Cytol Pathol 2001, 33:245-249.
44. van den Tweel E.R., Kavelaars A., Lombardi M.S., Groenendaal F., May M., Heijnen C.J., van Bel F. Selective inhibition of nuclear factor-kappaB activation after hypoxia/ischemia in neonatal rats is not neuroprotective. Pediatr Res 2006, 59:232-236.